Reflections on the regulatory field covering the development of paediatric medicinal products: a brief overview of current status and challenges
Many medicinal products are initially developed and tested in adults, and often, only a limited amount of data on their safety and efficacy in children exist. Consequently, paediatric healthcare providers sometimes need to make informed decisions about using medicinal products in children based on a...
Saved in:
Main Author: | Birka Lehmann (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation (EC) No 1901/2006 on medicinal products for paediatric use & clinical research in vulnerable populations
by: Lehmann Birka
Published: (2008) -
Current status of herbal product: Regulatory overview
by: Sanjay Sharma
Published: (2015) -
Nanosystems in Cosmetic Products: A Brief Overview of Functional, Market, Regulatory and Safety Concerns
by: Chiara Ferraris, et al.
Published: (2021) -
Valsartan recall: global regulatory overview and future challenges
by: Muhammad Junaid Farrukh, et al.
Published: (2019) -
Biosimilars: Current regulatory perspective and challenges
by: Diwakar Jha, et al.
Published: (2013)